ReShape Lifesciences Inc - RSLS Company Cumulative Debt

ReShape Lifesciences Inc (RSLS) - corporate logo

ReShape Lifesciences (RSLS) is currently undergoing a labor-intensive merger with a niche developer, leaving its growth strategy fully focused on asset integration. This chart reflects the company's price action during a period when the standalone debt metric stands at 0.00. The business relies on the production of Lap-Band systems, gaining an edge through minimally invasive procedures and as an alternative to GLP-1 drugs. The team attracts experts via wellness-sector innovations and generous bonuses.

Company Aggregate Debts: reshapelifesciences.com (RSLS) for 07/04/2022 - 08/30/2025

ReShape Lifesciences - analytical breakdowns and key metrics (RSLS)

- price and consensus price forecast:
Price Performance Chart reshapelifesciences.com|RSLS - Analyst Consensus Forecast
- market capitalization data:
Market Value ReShape Lifesciences Inc|RSLS - Total Company Value
- book capitalization data:
Accounting Value of a Share ReShape Lifesciences|RSLS - Book Capitalization|Market Capitalization to Book Value Ratio reshapelifesciences.com|RSLS - Aggregate Company Assets
- debt and liquidity data:
Aggregate Debt to Equity ReShape Lifesciences|RSLS - Long-Term Debt to Capital|Current Liabilities to Capital reshapelifesciences.com|RSLS - Company Total Debt|Debts to Book Capitalization ReShape Lifesciences Inc
General company analysis:RSLS (ReShape Lifesciences, Inc.)
Signature product of ReShape Lifesciences Inc

ReShape Lifesciences (RSLS) is optimizing production costs for Lap-Band systems by outsourcing assembly and sterilization to US contractors. The trend in total debt reflects the sum of all credit obligations, allowing investors to assess the balance between financial stability and the pace of business growth amid macroeconomic volatility.

Analysis of competing companies

Aggregate Debt Obligations Dexcom CGM (DXCM)|PEN: Company Aggregate Debts|novanta.com - Company Cumulative Debt|Company Debts Haemonetics (HAE)|INSP - Aggregate Debt Obligations|PRCT: Company Aggregate Debts|CNMD (CONMED Inc.) - Company Aggregate Debts|Company Debts Pulse Biosciences, Inc. PLSE|Company Aggregate Indebtedness inmodemd.com|Picard Medical - Company Aggregate Debts|Company Cumulative Debt Surmodics Inc SRDX|Company Total Debt SENS (senseonics.com)|NPCE - Company Aggregate Debts|Company Total Debt Tactile Systems Technology Inc. TCMD|SNWV - Company Cumulative Indebtedness|Outset Medical - Company Aggregate Debts|Electromed (ELMD) - Company Total Debt Obligations|Company Aggregate Debts LNSR|Company Total Debt AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Company Total Debt|Aggregate Debt Obligations BDMD (bairdmed.com)|EDAP TMS - Company Debts|Company Total Debt Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Company Aggregate Debts|LUNG - Company Cumulative Debt|Company Aggregate Debts telabio.com|CytoSorbents Corporation (CTSO) - Company Aggregate Debt|SRTS: Company Aggregate Debts|Company Total Debt Obligations Zynex Medical|Company Aggregate Debts ECOR (electroCore, Inc.)|Company Total Debt vicarioussurgical.com (RBOT)|Company Aggregate Debts IINN (Inspira Technologies)|seastarmedical.com - Company Aggregate Debts|IRIX - Company Debts|Intelligent Bio Solutions (INBS) - Company Debts|Company Total Debt beyondair.net XAIR|Profusa, Inc (PFSA) - Aggregate Debt Obligations|Company Aggregate Debts SSKN (STRATA Skin Sciences Inc.)|Company Cumulative Debt GCTK|NAOV: Company Debts|Company Total Indebtedness Venus Concept Inc VERO|Company Total Debt NUWE (CHF Solutions)|Company Aggregate Debts Aethlon Medical Corp AEMD|Company Aggregate Debts ASXC (TransEnterix)|AVGR: Company Total Debt Obligations|Company Debts Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Company Aggregate Indebtedness|Company Debts KNW|Company Total Debt Inari Medical Corp|Nevro Corp. - Company Aggregate Debts|Company Cumulative Debt SILK (silkroadmed.com)